nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.167	0.249	CbGbCtD
Orphenadrine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.146	0.217	CbGbCtD
Orphenadrine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0716	0.107	CbGbCtD
Orphenadrine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0713	0.106	CbGbCtD
Orphenadrine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0552	0.0824	CbGbCtD
Orphenadrine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0514	0.0766	CbGbCtD
Orphenadrine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.048	0.0716	CbGbCtD
Orphenadrine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0236	0.0352	CbGbCtD
Orphenadrine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0216	0.0322	CbGbCtD
Orphenadrine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0147	0.022	CbGbCtD
Orphenadrine—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00328	0.0195	CcSEcCtD
Orphenadrine—GRIN1—ganglion—peripheral nervous system neoplasm	0.00283	0.166	CbGeAlD
Orphenadrine—Amitriptyline—NTRK2—peripheral nervous system neoplasm	0.00261	0.212	CrCbGaD
Orphenadrine—Cyclopentolate—BCHE—peripheral nervous system neoplasm	0.00244	0.198	CrCbGaD
Orphenadrine—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00239	0.0142	CcSEcCtD
Orphenadrine—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00239	0.0142	CcSEcCtD
Orphenadrine—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.00214	0.0127	CcSEcCtD
Orphenadrine—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.00214	0.0127	CcSEcCtD
Orphenadrine—Tension—Tretinoin—peripheral nervous system neoplasm	0.00183	0.0109	CcSEcCtD
Orphenadrine—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.0109	CcSEcCtD
Orphenadrine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.0108	CcSEcCtD
Orphenadrine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00176	0.0105	CcSEcCtD
Orphenadrine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00176	0.0105	CcSEcCtD
Orphenadrine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00175	0.0104	CcSEcCtD
Orphenadrine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00175	0.0104	CcSEcCtD
Orphenadrine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00172	0.0102	CcSEcCtD
Orphenadrine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00172	0.0102	CcSEcCtD
Orphenadrine—SCN10A—nerve—peripheral nervous system neoplasm	0.00171	0.1	CbGeAlD
Orphenadrine—SCN10A—ganglion—peripheral nervous system neoplasm	0.00169	0.099	CbGeAlD
Orphenadrine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00165	0.00981	CcSEcCtD
Orphenadrine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00165	0.00981	CcSEcCtD
Orphenadrine—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.00961	CcSEcCtD
Orphenadrine—Amitriptyline—NTRK1—peripheral nervous system neoplasm	0.00161	0.131	CrCbGaD
Orphenadrine—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00156	0.00926	CcSEcCtD
Orphenadrine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00154	0.00913	CcSEcCtD
Orphenadrine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00154	0.00913	CcSEcCtD
Orphenadrine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00154	0.00913	CcSEcCtD
Orphenadrine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00906	CcSEcCtD
Orphenadrine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00906	CcSEcCtD
Orphenadrine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00151	0.00894	CcSEcCtD
Orphenadrine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00149	0.00887	CcSEcCtD
Orphenadrine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00149	0.00884	CcSEcCtD
Orphenadrine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00149	0.00884	CcSEcCtD
Orphenadrine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00148	0.0088	CcSEcCtD
Orphenadrine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00148	0.0088	CcSEcCtD
Orphenadrine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.00148	0.12	CrCbGaD
Orphenadrine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00147	0.00873	CcSEcCtD
Orphenadrine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00146	0.00868	CcSEcCtD
Orphenadrine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00825	CcSEcCtD
Orphenadrine—GRIN2D—brainstem—peripheral nervous system neoplasm	0.00138	0.081	CbGeAlD
Orphenadrine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00136	0.00805	CcSEcCtD
Orphenadrine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00136	0.00805	CcSEcCtD
Orphenadrine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00793	CcSEcCtD
Orphenadrine—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00133	0.0079	CcSEcCtD
Orphenadrine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00788	CcSEcCtD
Orphenadrine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00131	0.00781	CcSEcCtD
Orphenadrine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.00775	CcSEcCtD
Orphenadrine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.0013	0.00775	CcSEcCtD
Orphenadrine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00773	CcSEcCtD
Orphenadrine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00127	0.00752	CcSEcCtD
Orphenadrine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00126	0.00746	CcSEcCtD
Orphenadrine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00126	0.00746	CcSEcCtD
Orphenadrine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00125	0.00745	CcSEcCtD
Orphenadrine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00743	CcSEcCtD
Orphenadrine—GRIN1—brainstem—peripheral nervous system neoplasm	0.00123	0.0722	CbGeAlD
Orphenadrine—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00731	CcSEcCtD
Orphenadrine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00122	0.00725	CcSEcCtD
Orphenadrine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.0072	CcSEcCtD
Orphenadrine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00121	0.0072	CcSEcCtD
Orphenadrine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0012	0.0071	CcSEcCtD
Orphenadrine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00692	CcSEcCtD
Orphenadrine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00687	CcSEcCtD
Orphenadrine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00675	CcSEcCtD
Orphenadrine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00113	0.00673	CcSEcCtD
Orphenadrine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00113	0.00671	CcSEcCtD
Orphenadrine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.0067	CcSEcCtD
Orphenadrine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00112	0.00667	CcSEcCtD
Orphenadrine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00112	0.00667	CcSEcCtD
Orphenadrine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00667	CcSEcCtD
Orphenadrine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00111	0.00662	CcSEcCtD
Orphenadrine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00111	0.00659	CcSEcCtD
Orphenadrine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.0011	0.00655	CcSEcCtD
Orphenadrine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.0065	CcSEcCtD
Orphenadrine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00109	0.0065	CcSEcCtD
Orphenadrine—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.00109	0.0639	CbGeAlD
Orphenadrine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00109	0.00646	CcSEcCtD
Orphenadrine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00108	0.00642	CcSEcCtD
Orphenadrine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00641	CcSEcCtD
Orphenadrine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00641	CcSEcCtD
Orphenadrine—SLC6A2—nerve—peripheral nervous system neoplasm	0.00107	0.0624	CbGeAlD
Orphenadrine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00106	0.00633	CcSEcCtD
Orphenadrine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00105	0.0616	CbGeAlD
Orphenadrine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.0061	CcSEcCtD
Orphenadrine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00103	0.0061	CcSEcCtD
Orphenadrine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00102	0.00604	CcSEcCtD
Orphenadrine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00599	CcSEcCtD
Orphenadrine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00599	CcSEcCtD
Orphenadrine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000988	0.00587	CcSEcCtD
Orphenadrine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000985	0.00585	CcSEcCtD
Orphenadrine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000977	0.00581	CcSEcCtD
Orphenadrine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00097	0.00576	CcSEcCtD
Orphenadrine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00097	0.00576	CcSEcCtD
Orphenadrine—Headache—Topotecan—peripheral nervous system neoplasm	0.000963	0.00572	CcSEcCtD
Orphenadrine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000961	0.00571	CcSEcCtD
Orphenadrine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000957	0.00568	CcSEcCtD
Orphenadrine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000956	0.00568	CcSEcCtD
Orphenadrine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000955	0.00567	CcSEcCtD
Orphenadrine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000955	0.00567	CcSEcCtD
Orphenadrine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000952	0.00566	CcSEcCtD
Orphenadrine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000952	0.00566	CcSEcCtD
Orphenadrine—Reboxetine—ABCB1—peripheral nervous system neoplasm	0.000926	0.0752	CrCbGaD
Orphenadrine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000918	0.00545	CcSEcCtD
Orphenadrine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000918	0.00545	CcSEcCtD
Orphenadrine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000913	0.00542	CcSEcCtD
Orphenadrine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00091	0.0054	CcSEcCtD
Orphenadrine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000906	0.00538	CcSEcCtD
Orphenadrine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000906	0.00538	CcSEcCtD
Orphenadrine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000902	0.00536	CcSEcCtD
Orphenadrine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000894	0.00531	CcSEcCtD
Orphenadrine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000894	0.00531	CcSEcCtD
Orphenadrine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00088	0.00523	CcSEcCtD
Orphenadrine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000876	0.00521	CcSEcCtD
Orphenadrine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000851	0.00506	CcSEcCtD
Orphenadrine—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	0.00083	0.0487	CbGeAlD
Orphenadrine—SCN1A—brainstem—peripheral nervous system neoplasm	0.00083	0.0486	CbGeAlD
Orphenadrine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000829	0.00493	CcSEcCtD
Orphenadrine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000821	0.00487	CcSEcCtD
Orphenadrine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000818	0.00486	CcSEcCtD
Orphenadrine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000811	0.00482	CcSEcCtD
Orphenadrine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000802	0.00476	CcSEcCtD
Orphenadrine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000799	0.00475	CcSEcCtD
Orphenadrine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000793	0.00471	CcSEcCtD
Orphenadrine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000793	0.00471	CcSEcCtD
Orphenadrine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000771	0.00458	CcSEcCtD
Orphenadrine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000764	0.00454	CcSEcCtD
Orphenadrine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000743	0.00442	CcSEcCtD
Orphenadrine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00074	0.0044	CcSEcCtD
Orphenadrine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000736	0.00437	CcSEcCtD
Orphenadrine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000735	0.00436	CcSEcCtD
Orphenadrine—Toremifene—ABCB1—peripheral nervous system neoplasm	0.000735	0.0597	CrCbGaD
Orphenadrine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000734	0.00436	CcSEcCtD
Orphenadrine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000726	0.00431	CcSEcCtD
Orphenadrine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000724	0.0043	CcSEcCtD
Orphenadrine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000717	0.00426	CcSEcCtD
Orphenadrine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000708	0.00421	CcSEcCtD
Orphenadrine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000707	0.0042	CcSEcCtD
Orphenadrine—Headache—Vincristine—peripheral nervous system neoplasm	0.000698	0.00414	CcSEcCtD
Orphenadrine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.00408	CcSEcCtD
Orphenadrine—GRIN2D—cerebellum—peripheral nervous system neoplasm	0.000682	0.0399	CbGeAlD
Orphenadrine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000665	0.00395	CcSEcCtD
Orphenadrine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000662	0.00393	CcSEcCtD
Orphenadrine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000647	0.00384	CcSEcCtD
Orphenadrine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000638	0.00379	CcSEcCtD
Orphenadrine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000626	0.00372	CcSEcCtD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000621	0.00471	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000619	0.00469	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000614	0.00465	CbGpPWpGaD
Orphenadrine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000608	0.00361	CcSEcCtD
Orphenadrine—GRIN1—cerebellum—peripheral nervous system neoplasm	0.000608	0.0356	CbGeAlD
Orphenadrine—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000597	0.00453	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000597	0.00453	CbGpPWpGaD
Orphenadrine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000597	0.00354	CcSEcCtD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000596	0.00451	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000593	0.0045	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000587	0.00445	CbGpPWpGaD
Orphenadrine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000585	0.00347	CcSEcCtD
Orphenadrine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000584	0.00347	CcSEcCtD
Orphenadrine—Fluoxetine—ABCB1—peripheral nervous system neoplasm	0.000581	0.0472	CrCbGaD
Orphenadrine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000574	0.00341	CcSEcCtD
Orphenadrine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000569	0.00338	CcSEcCtD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000569	0.00431	CbGpPWpGaD
Orphenadrine—Headache—Etoposide—peripheral nervous system neoplasm	0.000565	0.00336	CcSEcCtD
Orphenadrine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000564	0.00427	CbGpPWpGaD
Orphenadrine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.00334	CcSEcCtD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000557	0.00422	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000553	0.00419	CbGpPWpGaD
Orphenadrine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000548	0.00325	CcSEcCtD
Orphenadrine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00321	CcSEcCtD
Orphenadrine—GRIN1—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000539	0.00408	CbGpPWpGaD
Orphenadrine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000536	0.00318	CcSEcCtD
Orphenadrine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000527	0.00313	CcSEcCtD
Orphenadrine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00051	0.00303	CcSEcCtD
Orphenadrine—HRH1—IL-4 Signaling Pathway—BIRC5—peripheral nervous system neoplasm	0.000509	0.00385	CbGpPWpGaD
Orphenadrine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.00301	CcSEcCtD
Orphenadrine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000506	0.003	CcSEcCtD
Orphenadrine—GRIN1—EPHB-mediated forward signaling—HRAS—peripheral nervous system neoplasm	0.000497	0.00376	CbGpPWpGaD
Orphenadrine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000497	0.00376	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000495	0.00375	CbGpPWpGaD
Orphenadrine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000494	0.00293	CcSEcCtD
Orphenadrine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000491	0.00292	CcSEcCtD
Orphenadrine—GRIN1—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000489	0.0037	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000481	0.00364	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000479	0.00363	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000478	0.00362	CbGpPWpGaD
Orphenadrine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.0028	CcSEcCtD
Orphenadrine—SLC6A2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000471	0.00357	CbGpPWpGaD
Orphenadrine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.00278	CcSEcCtD
Orphenadrine—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.000464	0.0272	CbGeAlD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000464	0.00351	CbGpPWpGaD
Orphenadrine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000457	0.0268	CbGeAlD
Orphenadrine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.00271	CcSEcCtD
Orphenadrine—GRIN1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000456	0.00346	CbGpPWpGaD
Orphenadrine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.0027	CcSEcCtD
Orphenadrine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00045	0.00267	CcSEcCtD
Orphenadrine—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000442	0.00335	CbGpPWpGaD
Orphenadrine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000432	0.00257	CcSEcCtD
Orphenadrine—GRIN2D—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000429	0.00325	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000426	0.00323	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000426	0.00323	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00042	0.00318	CbGpPWpGaD
Orphenadrine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000417	0.00248	CcSEcCtD
Orphenadrine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.00247	CcSEcCtD
Orphenadrine—GRIN1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000413	0.00313	CbGpPWpGaD
Orphenadrine—SCN1A—cerebellum—peripheral nervous system neoplasm	0.000409	0.024	CbGeAlD
Orphenadrine—HRH1—IL-4 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.000408	0.00309	CbGpPWpGaD
Orphenadrine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000402	0.00239	CcSEcCtD
Orphenadrine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.00238	CcSEcCtD
Orphenadrine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.00229	CcSEcCtD
Orphenadrine—KCNH2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00038	0.00288	CbGpPWpGaD
Orphenadrine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000373	0.00221	CcSEcCtD
Orphenadrine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000372	0.0218	CbGeAlD
Orphenadrine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.00221	CcSEcCtD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000366	0.00278	CbGpPWpGaD
Orphenadrine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000363	0.00216	CcSEcCtD
Orphenadrine—SLC6A2—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000361	0.00274	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00036	0.00273	CbGpPWpGaD
Orphenadrine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000358	0.00213	CcSEcCtD
Orphenadrine—GRIN1—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000349	0.00264	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000348	0.00263	CbGpPWpGaD
Orphenadrine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.00205	CcSEcCtD
Orphenadrine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00034	0.00258	CbGpPWpGaD
Orphenadrine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.00199	CcSEcCtD
Orphenadrine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000334	0.00199	CcSEcCtD
Orphenadrine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.00197	CcSEcCtD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00033	0.0025	CbGpPWpGaD
Orphenadrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000324	0.00245	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	0.000322	0.00244	CbGpPWpGaD
Orphenadrine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000322	0.00191	CcSEcCtD
Orphenadrine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000317	0.00188	CcSEcCtD
Orphenadrine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.00184	CcSEcCtD
Orphenadrine—GRIN1—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000307	0.00233	CbGpPWpGaD
Orphenadrine—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.000307	0.0249	CrCbGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000303	0.00229	CbGpPWpGaD
Orphenadrine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.0003	0.00178	CcSEcCtD
Orphenadrine—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.0003	0.00227	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000298	0.00226	CbGpPWpGaD
Orphenadrine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00177	CcSEcCtD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000297	0.00225	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000296	0.00225	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	0.000296	0.00224	CbGpPWpGaD
Orphenadrine—Promethazine—ABCB1—peripheral nervous system neoplasm	0.000295	0.024	CrCbGaD
Orphenadrine—Tamoxifen—ABCB1—peripheral nervous system neoplasm	0.000293	0.0238	CrCbGaD
Orphenadrine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.00174	CcSEcCtD
Orphenadrine—Doxepin—ABCB1—peripheral nervous system neoplasm	0.000292	0.0237	CrCbGaD
Orphenadrine—Methadone—ABCB1—peripheral nervous system neoplasm	0.000291	0.0236	CrCbGaD
Orphenadrine—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	0.000285	0.00216	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.000285	0.00216	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000285	0.00216	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000279	0.00211	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000278	0.00211	CbGpPWpGaD
Orphenadrine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00165	CcSEcCtD
Orphenadrine—CHRM2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000274	0.00208	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000274	0.00207	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000271	0.00206	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000267	0.00203	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000264	0.002	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000264	0.002	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000263	0.00199	CbGpPWpGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.00026	0.00197	CbGpPWpGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	0.000256	0.00194	CbGpPWpGaD
Orphenadrine—GRIN1—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000256	0.00194	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000249	0.00188	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000247	0.00187	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000239	0.00181	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000235	0.00178	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MET—peripheral nervous system neoplasm	0.000234	0.00177	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000232	0.00175	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.00023	0.00174	CbGpPWpGaD
Orphenadrine—Imipramine—ABCB1—peripheral nervous system neoplasm	0.000228	0.0185	CrCbGaD
Orphenadrine—Amitriptyline—ABCB1—peripheral nervous system neoplasm	0.000226	0.0184	CrCbGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000223	0.00169	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000222	0.00168	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000216	0.00164	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000216	0.00164	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000213	0.00161	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000211	0.0016	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000209	0.00158	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000209	0.00158	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000204	0.00154	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000204	0.00154	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000204	0.00154	CbGpPWpGaD
Orphenadrine—KCNH2—cerebellum—peripheral nervous system neoplasm	0.000202	0.0119	CbGeAlD
Orphenadrine—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000201	0.00152	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000195	0.00148	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000195	0.00148	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000188	0.00143	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000188	0.00143	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000186	0.00141	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000186	0.00141	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000182	0.00138	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000179	0.00136	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000178	0.00135	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000177	0.00134	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000173	0.00131	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000171	0.00129	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000168	0.00127	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MET—peripheral nervous system neoplasm	0.000167	0.00126	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000165	0.00125	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000165	0.00125	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000162	0.00123	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.00016	0.00122	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000159	0.0012	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000159	0.0012	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000158	0.0012	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000158	0.00119	CbGpPWpGaD
Orphenadrine—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000156	0.00914	CbGeAlD
Orphenadrine—CHRM2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000155	0.00118	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000154	0.00117	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000154	0.00117	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000151	0.00114	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000149	0.00113	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000149	0.00113	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000149	0.00113	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000147	0.00111	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000143	0.00109	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000143	0.00108	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000141	0.00107	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.00014	0.00106	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000137	0.00104	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000135	0.00102	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000135	0.00102	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000132	0.001	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000131	0.000993	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00013	0.000984	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000128	0.000969	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000125	0.00095	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000123	0.000934	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000123	0.000934	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000122	0.000923	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000121	0.00092	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.00012	0.000913	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00012	0.000906	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000119	0.000905	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000119	0.000903	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000118	0.000891	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000117	0.00089	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000117	0.000887	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000116	0.00088	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000116	0.00088	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000113	0.000858	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000113	0.000858	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000112	0.000846	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00011	0.00083	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000108	0.000822	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000108	0.000817	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	0.000107	0.000812	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000107	0.000811	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000107	0.000809	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000105	0.000793	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.0001	0.000759	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.85e-05	0.000746	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—HRAS—peripheral nervous system neoplasm	9.5e-05	0.00072	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.35e-05	0.000709	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—NRAS—peripheral nervous system neoplasm	9.27e-05	0.000702	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—HRAS—peripheral nervous system neoplasm	8.92e-05	0.000676	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	8.64e-05	0.000655	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.59e-05	0.000651	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	8.47e-05	0.000641	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.46e-05	0.000641	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.32e-05	0.00063	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	8.29e-05	0.000628	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.29e-05	0.000628	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	8.29e-05	0.000628	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.26e-05	0.000626	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	8.16e-05	0.000619	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.12e-05	0.000615	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	8.12e-05	0.000615	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.11e-05	0.000614	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.04e-05	0.000609	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	7.98e-05	0.000604	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.98e-05	0.000604	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	7.96e-05	0.000603	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	7.81e-05	0.000592	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.59e-05	0.000575	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.32e-05	0.000554	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	7.32e-05	0.000554	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.08e-05	0.000537	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.97e-05	0.000528	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.78e-05	0.000514	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.43e-05	0.000487	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.41e-05	0.000486	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.33e-05	0.00048	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.31e-05	0.000478	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.19e-05	0.000469	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.09e-05	0.000462	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.99e-05	0.000454	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	5.94e-05	0.00045	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.91e-05	0.000448	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	5.83e-05	0.000441	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.82e-05	0.000441	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.62e-05	0.000426	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.53e-05	0.000419	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.43e-05	0.000412	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	5.24e-05	0.000397	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.14e-05	0.00039	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	5.13e-05	0.000389	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.44e-05	0.000337	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	4.43e-05	0.000335	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.37e-05	0.000331	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	4.33e-05	0.000328	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.22e-05	0.00032	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	4.16e-05	0.000315	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.13e-05	0.000313	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	4.08e-05	0.000309	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.93e-05	0.000298	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.91e-05	0.000296	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.85e-05	0.000291	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.8e-05	0.000288	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.77e-05	0.000285	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.74e-05	0.000283	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.63e-05	0.000275	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.62e-05	0.000274	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.56e-05	0.00027	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	3.4e-05	0.000257	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.33e-05	0.000253	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	3.33e-05	0.000252	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.32e-05	0.000252	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.27e-05	0.000248	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.26e-05	0.000247	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.38e-05	0.00018	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.35e-05	0.000178	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.31e-05	0.000175	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.31e-05	0.000175	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.27e-05	0.000172	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.01e-05	0.000152	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.92e-05	0.000145	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.89e-05	0.000143	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.82e-05	0.000138	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.8e-05	0.000136	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.72e-05	0.00013	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.69e-05	0.000128	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000127	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.66e-05	0.000125	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.64e-05	0.000125	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.63e-05	0.000123	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.54e-05	0.000117	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.52e-05	0.000115	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.51e-05	0.000115	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.49e-05	0.000113	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.39e-05	0.000105	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.37e-05	0.000104	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.29e-05	9.8e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.27e-05	9.64e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.06e-05	8.05e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.05e-05	7.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.02e-05	7.7e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.99e-06	7.57e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	9.17e-06	6.95e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	8.98e-06	6.8e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.97e-06	6.79e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.82e-06	6.69e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.17e-06	3.16e-05	CbGpPWpGaD
